REAL-WORLD CLINICAL AND VIROLOGICAL OUTCOMES OF UNTREATED AND TENOFOVIR DISOPROXIL FUMARATE (TDF)-TREATED CHRONIC HEPATITIS B (CHB) PREGNANT PATIENTS IN A LOW HEPATITIS B VIRUS (HBV) ENDEMIC REGION

被引：0
|
作者：
Kochaksaraei, Golasa Samadi [1 ]
Shaheen, Abdel Aziz [1 ]
Castillo, Eliana [1 ]
Martin, Steven R. [1 ]
Israelson, Heidi [1 ]
Aspinall, Alex [1 ]
Borman, Meredith A. [1 ]
Congly, Stephen E. [1 ]
Stinton, Laura M. [1 ]
Lee, Samuel S. [1 ]
Coffin, Carla S. [1 ]
机构：
[1] Univ Calgary, Med, Calgary, AB, Canada
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
983
引用
收藏
页码：600A / 601A
页数：2
相关论文
共 50 条
  • [21] From Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF): Perspectives in Pediatric Patients with Chronic Hepatitis B
    Rodrigo, Minna
    Hartley, Christopher
    Wasuwanich, Paul
    Van, Trung
    Karnsakul, Wikrom
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2024, 22 (12) : 1099 - 1106
  • [22] Morphometric Assessment of Quantitative Collagen and Liver Fibrosis in Patients with Chronic Hepatitis B (CHB) Treated for up to Five Years with Tenofovir Disoproxil Fumarate (TDF)
    Goodman, Zachary D.
    Afdhal, Nezam H.
    Buti, Maria
    Gane, Edward J.
    Krastev, Zahary
    Schall, Raul E. Aguilar
    Kim, Sun Sook
    Alaparthi, Lakshmi
    Monge, Fanny
    Emmett, Caroline
    Bornstein, Jeffrey
    Subramanian, Mani
    McHutchison, John G.
    Dusheiko, Geoffrey M.
    Kaita, Kelly D.
    Manns, Michael P.
    Marcellin, Patrick
    HEPATOLOGY, 2013, 58 : 596A - 597A
  • [23] IS HBEAG LOSS ASSOCIATED WITH AN IMPROVED OUTCOME IN HEPATITIS B PATIENTS TREATED WITH TENOFOVIR DISOPROXIL FUMARATE (TDF)?
    Fung, S.
    Buti, M.
    Gane, E.
    Afdhal, N.
    Flaherty, J.
    Martins, E.
    Bekele, N.
    Bornstein, J.
    Marcellin, P.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S200 - S200
  • [24] Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide
    Hong, Hyeyeon
    Choi, Won-Mook
    Lee, Danbi
    Shim, Ju Hyun
    Kim, Kang Mo
    Lim, Young-Suk
    Lee, Han Chu
    Choi, Jonggi
    CLINICAL AND MOLECULAR HEPATOLOGY, 2024, 30 (01) : 49 - 63
  • [25] OUTCOMES OF EIGHT CHINESE-AMERICANS PREGNANT PATIENTS WITH CHRONIC HEPATITIS B (CHB) TREATED WITH TENOFOVIR DF (TDF) DURING PREGNANCY
    Mi, Li-Jun
    Karsdon, Jeffrey
    Huang, William M.
    Zhang, Jinghua
    Manheimer, Forrest
    Tran, Tram T.
    Brown, Robert S.
    Ghany, Marc G.
    HEPATOLOGY, 2010, 52 (04) : 505A - 505A
  • [26] Outcomes and characteristics of hepatocellular carcinomas (HCC) in Caucasian chronic hepatitis B (CHB) patients treated with long-term entecavir (ETV) or tenofovir disoproxil fumarate (TDF) therapy
    Papatheodoridis, George
    Dalekos, George
    Idilman, Ramazan
    Sypsa, Vana
    Buti, Maria
    Calleja Panero, Jose Luis
    Goulis, Ioannis
    Sonneveld, Milan
    van Bommel, Florian
    Manolakopoulos, Spilios
    Loglio, Alessandro
    Papatheodoridi, Margarita
    Gatselis, Nikolaos
    Lopez-Gomez, Marta
    Savvidou, Savvoula
    Brakenhoff, Sylvia
    Samakidou, Anna
    Yurdaydin, Cihan
    Esteban, Rafael
    Janssen, Harry
    Berg, Thomas
    Lampertico, Pietro
    JOURNAL OF HEPATOLOGY, 2021, 75 : S747 - S748
  • [27] Does Hepatic Steatosis Influence the Virological Response with Chronic Hepatitis B Patients Treated with Entecavir or Tenofovir Disoproxil Fumarate?
    Atalay, Roni
    Sayar, Suleyman
    Ayranci, Fatma Gulcicek
    Cakmak, Suheda
    Tanboga, Ibrahim Halil
    Doganay, Levent
    Ozdil, Kamil
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2022, 33 (07): : 587 - 595
  • [28] Hepatitis B Virus (HBV) Variants in Untreated and Tenofovir Treated Chronic Hepatitis B (CHB) Patients during Pregnancy and Post-Partum Follow-Up
    Virine, Boris
    Osiowy, Carla
    Gao, Shan
    Wang, Tong
    Castillo, Eliana
    Martin, Steven R.
    Lee, Samuel S.
    Simmonds, Kimberley
    van Marle, Guido
    Coffin, Carla S.
    PLOS ONE, 2015, 10 (10):
  • [29] SAFETY AND TOLERABILITY OF 96 WEEKS OF TENOFOVIR DISOPROXIL FUMARATE (TDF) TREATMENT IN HBeAg NEGATIVE AND POSITIVE PATIENTS INFECTED WITH CHRONIC HEPATITIS B (CHB)
    Marcellin, P.
    Heathcote, E. J.
    Jacobson, I.
    Mathurin, P.
    Gane, E.
    Buggisch, P.
    Husa, P.
    Krastev, Z.
    Sorbel, J.
    Anderson, J.
    Mondou, E.
    Rousseau, F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S336 - S337
  • [30] Tenofovir Disoproxil Fumarate (TDF) Versus Emtricitabine Plus TDF (FTC/TDF) for Treatment of Chronic Hepatitis B (CHB) in Patients with Persistent Viral Replication Receiving Adefovir Dipivoxil
    Berg, Thomas
    Moeller, Bernd
    Trinh, Huy N.
    Chan, Sing
    Marcellin, Patrick
    Suarez, Emilio
    Snow-Lampart, Andrea
    Oldach, David W.
    Sorbel, Jeff
    Borroto-Esoda, Katyna
    Frederick, David
    Rousseau, Franck
    GASTROENTEROLOGY, 2009, 136 (05) : A799 - A799
12345